BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9399050)

  • 1. Von Hippel-Lindau (VHL) gene analysis in Italian families with VHL disease.
    Montera M; Bellone E; Ajmar F; Mandich P
    Contrib Nephrol; 1997; 122():109-11. PubMed ID: 9399050
    [No Abstract]   [Full Text] [Related]  

  • 2. Genotype-phenotype correlation in von Hippel-Lindau disease: identification of a mutation associated with VHL type 2A.
    Chen F; Slife L; Kishida T; Mulvihill J; Tisherman SE; Zbar B
    J Med Genet; 1996 Aug; 33(8):716-7. PubMed ID: 8863170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal angiomatosis and von Hippel-Lindau disease.
    Kreusel KM; Bechrakis NE; Heinichen T; Neumann L; Neumann HP; Foerster MH
    Graefes Arch Clin Exp Ophthalmol; 2000 Nov; 238(11):916-21. PubMed ID: 11148816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene.
    Stolle C; Glenn G; Zbar B; Humphrey JS; Choyke P; Walther M; Pack S; Hurley K; Andrey C; Klausner R; Linehan WM
    Hum Mutat; 1998; 12(6):417-23. PubMed ID: 9829911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis of endothelial cells derived from von Hippel-Lindau-related renal cancer.
    Los M; Kerckhaert OA; Zewald R; van Amstel HK; Voest EE
    J Natl Cancer Inst; 2000 Oct; 92(20):1688-9. PubMed ID: 11036115
    [No Abstract]   [Full Text] [Related]  

  • 6. Three novel mutations in the Von Hippel-Lindau tumour suppressor gene in Italian patients.
    Mandich P; Montera M; Bellone E; Trojani A; Daniele S; Ajmar F
    Hum Mutat; 1998; Suppl 1():S268-70. PubMed ID: 9452106
    [No Abstract]   [Full Text] [Related]  

  • 7. Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations.
    Maher ER; Webster AR; Richards FM; Green JS; Crossey PA; Payne SJ; Moore AT
    J Med Genet; 1996 Apr; 33(4):328-32. PubMed ID: 8730290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VHL gene inactivation in an endolymphatic sac tumor associated with von Hippel-Lindau disease.
    Kawahara N; Kume H; Ueki K; Mishima K; Sasaki T; Kirino T
    Neurology; 1999 Jul; 53(1):208-10. PubMed ID: 10408561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Von Hippel-Lindau syndrome: hereditary cancer arising from inherited mutations of the VHL tumor suppressor gene.
    Humphrey JS; Klausner RD; Linehan WM
    Cancer Treat Res; 1996; 88():13-39. PubMed ID: 9239471
    [No Abstract]   [Full Text] [Related]  

  • 10. Somatic von Hippel-Lindau gene mutations detected in sporadic endolymphatic sac tumors.
    Vortmeyer AO; Huang SC; Koch CA; Governale L; Dickerman RD; McKeever PE; Oldfield EH; Zhuang Z
    Cancer Res; 2000 Nov; 60(21):5963-5. PubMed ID: 11085513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The von Hippel-Lindau tumor suppressor gene. A rare and intriguing disease opening new insight into basic mechanisms of carcinogenesis.
    Decker HJ; Weidt EJ; Brieger J
    Cancer Genet Cytogenet; 1997 Jan; 93(1):74-83. PubMed ID: 9062583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The kidney and von Hippel-Lindau disease: impact of molecular genetic analysis of the VHL gene for clinical management.
    Neumann HP; Bender BU; Schultze-Seemann W; Krause T; Altehoefer C; Scheremet R; Orszagh M; Schwarzkopf G; Januszewicz A; Janetschek G; Riegler P
    Contrib Nephrol; 1997; 122():102-8. PubMed ID: 9399049
    [No Abstract]   [Full Text] [Related]  

  • 13. [Von Hippel-Lindau disease].
    Shuin T; Ashida S; Yao M; Kanno H
    Nihon Rinsho; 2000 Jul; 58(7):1448-54. PubMed ID: 10921322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas.
    Dannenberg H; De Krijger RR; van der Harst E; Abbou M; IJzendoorn Y; Komminoth P; Dinjens WN
    Int J Cancer; 2003 Jun; 105(2):190-5. PubMed ID: 12673678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.
    Jensen RL; Gillespie D; House P; Layfield L; Shelton C
    J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [File no. 41. VHL (von Hippel-Lindau). Tumor suppressor gene].
    Soussi T
    Bull Cancer; 2000 Nov; 87(11):771-2. PubMed ID: 11190567
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of a novel mutation (c279delC) and a polymorphism (c291C>G) in the von Hippel-Lindau gene in Italian patients.
    Moore PS; Antonello D; Martignoni G; Racchini C; Ventrucci M; Scarpa A
    Hum Mutat; 2000 Jun; 15(6):582. PubMed ID: 10862095
    [No Abstract]   [Full Text] [Related]  

  • 18. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
    Zbar B
    Cancer Surv; 1995; 25():219-32. PubMed ID: 8718521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Von Hippel-Lindau syndrome. A pleomorphic condition.
    Friedrich CA
    Cancer; 1999 Dec; 86(11 Suppl):2478-82. PubMed ID: 10630173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Von Hippel-Lindau disease: how does one gene cause multiple tumors?
    Roach ES
    Neurology; 1999 Jul; 53(1):7-8. PubMed ID: 10408528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.